These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 7926292)

  • 21. Renal enlargement and insulin-like growth factor-1 accumulation in the Wistar rat model of experimental diabetes is not prevented by angiotensin converting enzyme inhibition.
    New JP; Canavan JP; Flyvbjerg A; Hamon G; Bilous RW; Marshall SM
    Diabetologia; 1996 Feb; 39(2):166-71. PubMed ID: 8635668
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Organ specificity of antihypertensive therapy on ocular albumin vascular clearance and albuminuria in the hypertensive diabetic rat.
    Gin T; Joon TL; Panagiotopoulos S; Cooper M; Taylor H; Jerums G
    Invest Ophthalmol Vis Sci; 1996 Feb; 37(2):281-9. PubMed ID: 8603832
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Angiotensin II induces cardiovascular hypertrophy in perindopril-treated rats.
    Black MJ; Bertram JF; Campbell JH; Campbell GR
    J Hypertens; 1995 Jun; 13(6):683-92. PubMed ID: 7594427
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chronic treatment with the angiotensin I converting enzyme inhibitor, perindopril, protects in vitro carbachol-induced vasorelaxation in a rat model of vascular calcium overload.
    Henrion D; Chillon JM; Capdeville-Atkinson C; Vinceneux-Feugier M; Atkinson J
    Br J Pharmacol; 1991 Dec; 104(4):966-72. PubMed ID: 1667295
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevention of endothelial dysfunction in small and large arteries in a model of chronic heart failure. Effect of angiotensin converting enzyme inhibition.
    Thuillez C; Mulder P; Elfertak L; Blaysat G; Compagnon P; Henry JP; Richard V; Scalbert E; Desche P
    Am J Hypertens; 1995 May; 8(5 Pt 2):7S-12S. PubMed ID: 7646844
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential efficacy of perindopril and enalapril in experimental diabetic nephropathy.
    Duggan KA; Hodge G; Makarious MM; Charlesworth JA
    Clin Exp Pharmacol Physiol; 1996; 23(6-7):608-10. PubMed ID: 8800600
    [TBL] [Abstract][Full Text] [Related]  

  • 27. No persistent effect of angiotensin converting enzyme inhibitor treatment in Milan hypertensive rats despite regression of vascular structure.
    Mulvany MJ; Persson AE; Andresen J
    J Hypertens; 1991 Jul; 9(7):589-93. PubMed ID: 1653793
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of ACE inhibition on the expression of type IV collagen and laminin in renal glomeruli in experimental diabetes.
    Erensoy N; Yilmazer S; Oztürk M; Tunçdemir M; Uysal O; Hatemi H
    Acta Histochem; 2004; 106(4):279-87. PubMed ID: 15350810
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effects of perindopril on vascular smooth muscle polyploidy in stroke-prone spontaneously hypertensive rats.
    Devlin AM; Gordon JF; Davidson AO; Clark JS; Hamilton CA; Morton JJ; Campbell AM; Reid JL; Dominiczak AF
    J Hypertens; 1995 Feb; 13(2):211-8. PubMed ID: 7615951
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of angiotensin-converting enzyme inhibition on skeletal muscle oxidative function and exercise capacity in streptozotocin-induced diabetic rats.
    Rouyer O; Zoll J; Daussin F; Damgé C; Helms P; Talha S; Rasseneur L; Piquard F; Geny B
    Exp Physiol; 2007 Nov; 92(6):1047-56. PubMed ID: 17675412
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acute but not chronic angiotensin-converting enzyme inhibition induces enzyme synthesis in the glomerulus of the spontaneously hypertensive rat.
    Hodge G; Makarious MM; Charlesworth JA; Duggan KA
    Clin Exp Pharmacol Physiol; 1997 Jun; 24(6):460-2. PubMed ID: 9171960
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endothelin receptor antagonism ameliorates mast cell infiltration, vascular hypertrophy, and epidermal growth factor expression in experimental diabetes.
    Gilbert RE; Rumble JR; Cao Z; Cox AJ; van Eeden P; Allen TJ; Kelly DJ; Cooper ME
    Circ Res; 2000 Feb; 86(2):158-65. PubMed ID: 10666411
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SPARC gene expression is increased in diabetes-related mesenteric vascular hypertrophy.
    Jandeleit-Dahm K; Rumble J; Cox AJ; Kelly DJ; Dziadek M; Cooper ME; Gilbert RE
    Microvasc Res; 2000 Jan; 59(1):61-71. PubMed ID: 10625572
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cardiovascular hypertrophy in diabetic spontaneously hypertensive rats: optimizing blockade of the renin-angiotensin system.
    Lassila M; Davis BJ; Allen TJ; Burrell LM; Cooper ME; Cao Z
    Clin Sci (Lond); 2003 Apr; 104(4):341-7. PubMed ID: 12653675
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diabetes-induced vascular hypertrophy is accompanied by activation of Na(+)-H(+) exchange and prevented by Na(+)-H(+) exchange inhibition.
    Jandeleit-Dahm K; Hannan KM; Farrelly CA; Allen TJ; Rumble JR; Gilbert RE; Cooper ME; Little PJ
    Circ Res; 2000 Dec; 87(12):1133-40. PubMed ID: 11110770
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interaction between neutral endopeptidase and angiotensin converting enzyme inhibition in rats with myocardial infarction: effects on cardiac hypertrophy and angiotensin and bradykinin peptide levels.
    Duncan AM; James GM; Anastasopoulos F; Kladis A; Briscoe TA; Campbell DJ
    J Pharmacol Exp Ther; 1999 Apr; 289(1):295-303. PubMed ID: 10087017
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of angiotensin II and bradykinin in experimental diabetic nephropathy. Functional and structural studies.
    Allen TJ; Cao Z; Youssef S; Hulthen UL; Cooper ME
    Diabetes; 1997 Oct; 46(10):1612-8. PubMed ID: 9313758
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Angiotensin-converting enzyme inhibition and salt in experimental myocardial infarction.
    Yoshida K; Kohzuki M; Casley DJ; Johnston CI
    J Cardiovasc Pharmacol; 1998 Sep; 32(3):357-65. PubMed ID: 9733347
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diabetic renal microvascular disease: the role of hypertension and ACE inhibitors.
    Cooper ME; Rumble JR; Gin T; Lim-Joon T
    Clin Exp Pharmacol Physiol Suppl; 1992; 19():23-7. PubMed ID: 1395113
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oral magnesium administration prevents vascular complications in STZ-diabetic rats.
    Soltani N; Keshavarz M; Sohanaki H; Dehpour AR; Zahedi Asl S
    Life Sci; 2005 Feb; 76(13):1455-64. PubMed ID: 15680310
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.